A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer

Clinical trial NCT05662670 · TERMINATED

Trial details

NCT number: NCT05662670
Sponsor: Suzhou Junjing BioSciences Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic NSCLC

Start date: 2022-10-11
Primary completion: 2023-10-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.